ATE493649T1 - Verfahren zur diagnose von polyzystischer nierenkrankheit - Google Patents

Verfahren zur diagnose von polyzystischer nierenkrankheit

Info

Publication number
ATE493649T1
ATE493649T1 AT07700227T AT07700227T ATE493649T1 AT E493649 T1 ATE493649 T1 AT E493649T1 AT 07700227 T AT07700227 T AT 07700227T AT 07700227 T AT07700227 T AT 07700227T AT E493649 T1 ATE493649 T1 AT E493649T1
Authority
AT
Austria
Prior art keywords
kidney disease
polycystic kidney
diagnosing
diagnosing polycystic
pkd
Prior art date
Application number
AT07700227T
Other languages
English (en)
Inventor
Gerd Walz
Original Assignee
Universitaetsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg filed Critical Universitaetsklinikum Freiburg
Application granted granted Critical
Publication of ATE493649T1 publication Critical patent/ATE493649T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Die Bonding (AREA)
  • Adhesive Tapes (AREA)
  • External Artificial Organs (AREA)
AT07700227T 2006-01-17 2007-01-17 Verfahren zur diagnose von polyzystischer nierenkrankheit ATE493649T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06000963A EP1808694A1 (de) 2006-01-17 2006-01-17 Verfahren zur Diagnose von polyzystischer Nierenerkrankung
PCT/EP2007/000384 WO2007082733A1 (en) 2006-01-17 2007-01-17 Method for diagnosing polycystic kidney disease

Publications (1)

Publication Number Publication Date
ATE493649T1 true ATE493649T1 (de) 2011-01-15

Family

ID=35945115

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07700227T ATE493649T1 (de) 2006-01-17 2007-01-17 Verfahren zur diagnose von polyzystischer nierenkrankheit

Country Status (8)

Country Link
US (1) US20110229895A1 (de)
EP (3) EP1808694A1 (de)
AT (1) ATE493649T1 (de)
DE (1) DE602007011566D1 (de)
DK (2) DK2341344T3 (de)
ES (2) ES2475540T3 (de)
PL (2) PL1974210T3 (de)
WO (1) WO2007082733A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0710442A2 (pt) * 2006-02-09 2011-08-16 Novartis Ag agentes de ligação de proteìna-4 secretada relacionada com frizzled(sfrp-4)
EP3358354B1 (de) 2008-01-18 2020-07-15 President and Fellows of Harvard College Verfahren zur detektion von anzeichen einer krankheit oder eines leidens in körperflüssigkeiten
WO2009132815A1 (en) 2008-04-30 2009-11-05 Roche Diagnostics Gmbh Use of sfrp-3 in the assessment of heart failure
US20110297543A1 (en) * 2008-12-17 2011-12-08 Mosaques Diagnostics and Therapeutics AG Autosomal-Dominant Polycystic Kidney Disease (ADPKD)
CA2779905A1 (en) * 2009-11-07 2011-05-12 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010336392B2 (en) * 2009-12-23 2014-01-23 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a canine
BR112013001754A2 (pt) 2010-07-23 2016-05-31 Harvard College método para detectar marcas de doença ou condições em fluídos corpóreos
WO2012012694A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
WO2012012704A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting kidney-associated diseases or conditions
EP2596353A4 (de) 2010-07-23 2014-01-15 Harvard College Verfahren zum nachweis pränataler oder schwangerschaftsvermittelter krankheiten oder leiden
BR112013001752A2 (pt) 2010-07-23 2016-05-31 Harvard College método de detectar doenças ou condições usando células fagocídicas
EP3062108B1 (de) * 2011-02-24 2019-06-19 Hill's Pet Nutrition, Inc. Verfahren zur diagnostizierung von nierenerkrankungen bei katzen
US10494675B2 (en) 2013-03-09 2019-12-03 Cell Mdx, Llc Methods of detecting cancer
US11585814B2 (en) 2013-03-09 2023-02-21 Immunis.Ai, Inc. Methods of detecting prostate cancer
WO2014197729A1 (en) * 2013-06-05 2014-12-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN106716136B (zh) 2014-08-04 2020-06-23 建新公司 多囊性肾病的生物标志物及其用途
EP3693742B1 (de) 2014-09-11 2022-04-06 Harry Stylli Verfahren zum nachweis von prostatakrebs
CN107847462B (zh) 2015-03-13 2021-08-10 美国印第安纳大学研究和技术公司 靶向cGMP相关的磷酸二酯酶以减少囊性肾病的囊肿形成和相关的材料与方法
US10531837B1 (en) 2015-09-25 2020-01-14 Cerner Innovation, Inc. Predicting chronic kidney disease progression
JP6895963B2 (ja) 2015-11-18 2021-06-30 ジェンザイム・コーポレーション 多発性嚢胞腎のバイオマーカーおよびその使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0879885A1 (de) * 1997-05-23 1998-11-25 Smithkline Beecham Corporation GEN für ein sekretiertes-Maus-sFRP-1-Protein ähnliches Protein
US6638726B1 (en) * 2000-01-06 2003-10-28 Mount Sinai School Of Medicine Of New York University Screening methods for compounds useful in the treatment of polycystic kidney disease
EP1318840A2 (de) * 2000-07-19 2003-06-18 Genzyme Corporation Phosphatonin-verwandtes gen und verwendung
US20030143610A1 (en) * 2002-01-08 2003-07-31 Millennium Pharmaceuticals, Inc. Methods for the treatment of metabolic disorders, including obesity and diabetes
US7879544B2 (en) * 2002-07-29 2011-02-01 Hmgene Inc. Methods of identifying adipocyte specific genes, the genes identified, and their uses
US20040191818A1 (en) * 2003-02-26 2004-09-30 O'toole Margot Mary Compositions and methods for diagnosing and treating autoimmune diseases
WO2005070448A2 (en) * 2004-01-21 2005-08-04 Five Prime Therapeutics, Inc. Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
EP1740221A4 (de) * 2004-04-29 2009-01-07 Genzyme Corp Verfahren und zusammensetzungen zur behandlung von polyzystischen erkrankungen

Also Published As

Publication number Publication date
ES2356481T3 (es) 2011-04-08
PL2341344T3 (pl) 2014-09-30
ES2475540T3 (es) 2014-07-11
EP2341344B1 (de) 2014-04-30
EP2341344A1 (de) 2011-07-06
EP1974210A1 (de) 2008-10-01
EP1808694A1 (de) 2007-07-18
WO2007082733A1 (en) 2007-07-26
DE602007011566D1 (en) 2011-02-10
DK2341344T3 (da) 2014-06-30
US20110229895A1 (en) 2011-09-22
DK1974210T3 (da) 2011-02-21
EP1974210B1 (de) 2010-12-29
PL1974210T3 (pl) 2011-05-31

Similar Documents

Publication Publication Date Title
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
DE602005024639D1 (de) Verfahren und Gerät zur Diagnose des Ermüdungsversagens von Turboladern
DE112006000054A5 (de) Verfahren zur Diagnose eines Abgasnachbehandlungssystems
WO2006023412A3 (en) Biomarkers for osteoarthritis
NO20070949L (no) Transkriptomdiagnostikk i spytt
ATE511656T1 (de) Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis
WO2004112589A3 (en) Method for the detection of gene transcripts in blood and uses thereof
ATE492813T1 (de) Verfahren zur isolierung von analyten aus einer probe
ATE528410T1 (de) Verfahren und zusammensetzungen zur diagnose von altersbedingter maculadegeneration
ATE535805T1 (de) Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen
HK1159249A1 (en) Kit for the identification of ovarian cancer protein biomarkers using proteomic techniques
DE602007003833D1 (de) Verbesserte vitamin-d-messung
DE602007011541D1 (de) Verfahren zur Diagnose eines elektrisch betriebenen Laders
WO2010059242A3 (en) Neurodegenerative disease diagnostic compositions and methods of use
ATE478335T1 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
DE602006014798D1 (de) Vorrichtung und Verfahren zur Unterscheidung zwischen akuter und chronischer Myokardial-Nekrose bei symptomatischen Patienten
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
DE602005023157D1 (de) Verfahren zur diagnose von lawsonia intracellularis
DE602004024539D1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
WO2012178188A3 (en) Molecular diagnostic panel of eosinophilic gastrointestinal disorders
WO2006002240A3 (en) Computer systems and methods for constructing biological classifiers and uses thereof
WO2007134028A3 (en) Biomarkers for depression and methods using the same
ATE525481T1 (de) Verfahren zur diagnose thromboembolischer erkrankungen und koronarer herzerkrankungen
DE602008000683D1 (de) Immunassay-Verfahren, Reagenzienkit zur Erkennung einer Alkali-Phosphatase und Reagenzienkit für das Immunassay-Verfahren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1974210

Country of ref document: EP